Integration of contraceptive services into anticoagulation management services improves access to long-acting reversible contraception

Abstract

Objective: Integration of services is a promising way to improve access to contraception in sub-Saharan Africa, but few studies have evaluated this strategy to increase access to contraception among women requiring anticoagulation. Our objective was to evaluate a model of care integrating contraceptive counseling and provision within an anticoagulation management clinic in Eldoret, Kenya to determine the impact on LARC use.Study Design: We performed a prospective observational study of reproductive-age women referred for integrated services from the anticoagulation management clinic at Moi Teaching and Referral Hospital from March 2015 to March 2016. All participants received disease-specific contraceptive counseling and provision, free reversible methods (excluding hormonal intrauterine devices [IUDs]), and follow-up care. We compared LARC use 3 months post-intervention to pre-intervention using the proportions test. Logistic regression analysis was used to determine factors related to use of contraceptive implants and copper IUDs.Results: Of 190 participants, 171 (90%) completed 3-month follow-up. There was a significant increase in contraceptive implant use from 10% to 19%, p=0.02 and injectable contraceptive use from 14% to 24%, p=0.013. There was a concomitant decrease in the use of no method/abstinence from 57% to 39% (33% decrease, p<0.001). Younger age, having at least one child, and discussing family planning with a partner were predictive of LARC use.Conclusion: Integrating contraceptive services into an anticoagulation management clinic increases the use of highly effective contraceptive use for women with cardiovascular disease. Implementation of similar models of care should be evaluated within other sites for chronic disease management.Implications: A model of care integrating contraceptive counseling and provision into anticoagulation management services is an effective strategy to improve LARC and overall highly effective contraceptive use among women with cardiovascular disease requiring anticoagulation. This model of care may be utilized to prevent maternal morbidity and mortality among this high-risk population